Activity Description/ Purpose
Join members of our Gastrointestinal Disease Site Work Group as they address the challenges in treating gastrointestinal (GI) cancers. Surgeons will focus on identifying and tackling complex scenarios, especially rare cases, while learning techniques to apply fundamental knowledge to navigate these clinical challenges.
This interactive session aims to fill the gaps in traditional training, providing surgeons with diverse techniques for addressing the unique demands of rare GI surgical oncology cases, expanding their expertise in the field.
Faculty
The faculty for this activity are listed below:
Mio Kitano, MD (Moderator)
University of Texas Health San Antonio
Evan Glazer, MD, PhD, FACS, FSSO (Moderator)
University of Tennessee Health Science Center
Richelle Williams, MD (Moderator/Faculty)
University of Maryland Medical System
Wesley Papenfuss, MD (Faculty)
Aurora Health Care
Rebecca Kirschner, MD (Faculty)
Aurora Health Care - CGSO Fellow
Neil Newman, MD (Panelist)
University of Texas Health San Antonio MD Anderson Cancer Center
Yixing Jiang, MD (Panelist)
University of Maryland Medical System
Syma Iqbal, MD (Panelist)
Keck Medicine of USC
Target Audience
This activity is intended for all surgeons and other health care professionals who are involved in the treatment of patients with GI cancer.
Learning Objectives
At the conclusion of this activity, participants should be able to:
Identify challenges in scenarios for surgeons treating GI cancers.
Learn techniques to apply fundamental knowledge to rare and challenging
cases.
Accreditation
The Society of Surgical Oncology (SSO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The Society of Surgical Oncology designates this internet live course for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This internet live course offers a maximum of 1 self-assessment credit which may be applied to the American Board of Surgery (ABS) Continuous Certification program. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Requirements for Earning Credit and Method of Participation
This activity consists of educational content, an evaluation and self-assessment exam. Learners must view the activity content, complete the post-activity evaluation and self-assessment exam. A certificate of credit or participation will be available upon successful submission of the post-activity evaluation and self-assessment exam. Learners must achieve a passing score of 75% on the self-assessment exam.
Estimated Time to Complete Activity
The estimated time to complete this entire activity is 1 hour.
Release Date
February 27, 2024
CME Expiration Date
February 27, 2025
Disclosures
As required by the ACCME Standards for Integrity and Independence in Accredited Continuing Education, all planners, reviewers, presenters, instructors, moderators, authors, and other individuals in a position to control or influence the content of an activity must disclose ALL financial relationships with any ineligible company that have occurred within the past 24 months. Ineligible companies are those that cannot be accredited in the ACCME System and whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
As the accredited provider, SSO is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies and managing these to ensure they do not introduce commercial bias into the education. Financial relationships of any dollar amount are defined as relevant if the educational content is related to the business lines or products of the ineligible company.
All identified conflicts of interest must be mitigated, and the educational content vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. If you perceive bias while participating in this activity, please advise us of the circumstances when completing your postactivity evaluation form.
All identified conflicts of interests have been mitigated.
Faculty
Mio Kitano, MD (Moderator) has disclosed no financial relationships.
Evan Glazer, MD, PhD, FACS, FSSO (Moderator) has disclosed no financial relationships.
Richelle Williams, MD (Moderator/Faculty) has disclosed no financial relationships.
Wesley Papenfuss, MD (Faculty) has disclosed no financial relationships.
Rebecca Kirschner, MD (Faculty) has disclosed no financial relationships.
Neil Newman, MD (Panelist) has disclosed no financial relationships.
Yixing Jiang, MD (Panelist) has disclosed no financial relationships.
Syma Iqbal, MD (Panelist) has disclosed no financial relationships.
Planners, Reviewers, and Staff
Daniel Hewitt, CME Committee Reviewer, has disclosed no financial relationships.
Laura Dominici, CME Committee Reviewer, has disclosed no financial relationships.
Patti Stella, CAE, CHCP, Society of Surgical Oncology, has disclosed the following financial relationships - Horizon Therapeutics, SODR Biotech (XBI).
Meagan Gilliland-Johnson, Society of Surgical Oncology, has disclosed no financial relationships.
Devin Winkler, Society of Surgical Oncology, has disclosed no financial relationships.
Disclaimer
The primary purpose of the Society of Surgical Oncology's internet live course is educational. Information, as well as technologies, products, and/or services, discussed are intended to inform participants about the knowledge, techniques, and experiences of specialists who are willing to share such information with colleagues. A diversity of professional opinions exists in the specialty, and the Society of Surgical Oncology disclaims any and all liability for damages to any individual using the materials and for all claims which may result from the use of information, technologies, products, and/or services discussed.
Disclosure of Unlabeled Use
This educational activity may include discussions of unlabeled/unapproved uses of drugs or devices. Participants are advised to refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Opinions expressed in this educational activity are those of the expert contributors and do not necessarily represent the views of the Society of Surgical Oncology or any other organization associated with this activity.
Privacy and Confidentiality
For information about the Society of Surgical Oncology’s privacy policy and associated disclaimer, please visit this site: https://www.surgonc.org/about-sso/privacy-policy/ .
System Requirements
System requirements for this activity can be found by clicking the Help button. For technical support, please contact us at expertED@surgonc.org